172 related articles for article (PubMed ID: 17510970)
1. Differential prognostic impact of comorbidity in head and neck cancer.
Alho OP; Hannula K; Luokkala A; Teppo H; Koivunen P; Kantola S
Head Neck; 2007 Oct; 29(10):913-8. PubMed ID: 17510970
[TBL] [Abstract][Full Text] [Related]
2. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
3. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
4. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):603-7. PubMed ID: 18559726
[TBL] [Abstract][Full Text] [Related]
8. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.
Datema FR; Ferrier MB; van der Schroeff MP; Baatenburg de Jong RJ
Head Neck; 2010 Jun; 32(6):728-36. PubMed ID: 19827120
[TBL] [Abstract][Full Text] [Related]
9. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of comorbidity in salivary gland carcinoma.
Terhaard CH; van der Schroeff MP; van Schie K; Eerenstein SE; Lubsen H; Kaanders JH; Smeele LE; Burlage FR; van Den Ende PL; Baatenburg de Jong RJ
Cancer; 2008 Oct; 113(7):1572-9. PubMed ID: 18704992
[TBL] [Abstract][Full Text] [Related]
11. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
12. Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck.
Barra S; Barzan L; Maione A; Cadelano A; Pin M; Franceschi S; Comoretto R
Laryngoscope; 1994 Jan; 104(1 Pt 1):95-8. PubMed ID: 8295465
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract][Full Text] [Related]
14. The impact of comorbidity and age on survival with laryngeal cancer.
Sabin SL; Rosenfeld RM; Sundaram K; Har-el G; Lucente FE
Ear Nose Throat J; 1999 Aug; 78(8):578, 581-4. PubMed ID: 10485151
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
Golger A; Young DS; Ghazarian D; Neligan PC
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
[TBL] [Abstract][Full Text] [Related]
16. Age as a prognostic factor for complications of major head and neck surgery.
Boruk M; Chernobilsky B; Rosenfeld RM; Har-El G
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):605-9. PubMed ID: 16027283
[TBL] [Abstract][Full Text] [Related]
17. Relative importance of diagnostic delays in different head and neck cancers.
Teppo H; Alho OP
Clin Otolaryngol; 2008 Aug; 33(4):325-30. PubMed ID: 18983341
[TBL] [Abstract][Full Text] [Related]
18. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic relevance of age and comorbidity in patients with resected gastric cancer].
Bollschweiler E; Breckheimer S; Mönig SP; Hölscher AH
Zentralbl Chir; 2009 Feb; 134(1):71-6. PubMed ID: 19242886
[TBL] [Abstract][Full Text] [Related]
20. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
